Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.96 - $1.91 $144,576 - $287,646
-150,600 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.6 - $3.35 $240,960 - $504,510
150,600 New
150,600 $264,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0

About LEAP THERAPEUTICS, INC.


  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $292M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.